|
Mr. Morris brings more than 30 years of pharmaceutical, biomedical and biotechnology experience to Response Biomedical. For 21 years Mr. Morris held positions of increasing responsibility at Syntex Laboratories, culminating with the position of Director of manufacturing for Syntex's Palo Alto Operations in 1993. Mr. Morris then served as Vice President of Operations for Seattle and San Diego based Cypress Bioscience. Mr. Morris joined ID Biomedical in 2003 as Vice President of Operations. Upon the acquisition of the vaccine operations of Shire Pharmaceuticals by ID Biomedical, Mr. Morris became responsible for all North American Operations which included the 600 employee large scale influenza vaccine manufacturing facilities that supply in excess of 30 million doses of influenza vaccine to Canada and the United States. Upon the acquisition of ID Biomedical by Glaxo Smith Kline Biologicals, Mr. Morris also served as Vice President and General Manager of GSK's Bothell Washington Biodefense facility. | 